Breaking News

More () »

health

5 things we learned from EpiPen hearing

Congress heaped scorn upon the CEO of the drug company that makes the EpiPen treatment during a committee meeting Wednesday.

Mylan NV's EpiPen allergy shots sit on display for a photograph in Princeton, Illinois, U.S., on Friday, Aug. 26, 2016.

Congress heaped scorn upon the CEO of the drug company that makes the EpiPen treatment during a committee meeting Wednesday.

Here's what we learned from Mylan CEO Heather Bresch's testimony and questioning before the House Oversight panel.